Assessing surveillance utilization and value in commercially insured patients with colorectal cancer.

ABSTRACT:

Objectives

Real-world patterns of surveillance testing in colorectal cancer (CRC) and the effects on health and cost outcomes are largely unknown. Our objectives were to (1) assess trends in carcinoembryonic antigen (CEA) testing, CT scans, and colonoscopy utilization and (2) examine the value of CEA testing intensity by characterizing receipt of curative treatment for recurrence and measuring direct medical costs.

Study design

Prospective cohort study.

Methods

We used an IBM MarketScan database to identify patients with a diagnosis of and treatment for CRC between 2008 and 2015. We used a negative binomial model to assess utilization of CEA testing and logistic models to assess utilization of CT scans and colonoscopies. We used a Cox proportional hazards model to ass

SUBMITTER: Suh K 

PROVIDER: S-EPMC9316744 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature